TY - JOUR AU - Torrente-Segarra, Vicenc AU - Urruticoechea Arana, Ana AU - Sanchez-Andrade Fernandez, Amalia AU - Tovar Beltran, Juan Victor AU - Munoz Jimenez, Alejandro AU - Martinez-Cristobal, Anna AU - Gonzalez Ferrandez, Jose Antonio AU - Fernandez Prada, Manuel AU - Vazquez Fuentes, Noelia AU - Corominas, Hector AU - Garcia-Diaz, Silvia AU - Acosta Pereira, Asuncion AU - Ruiz Martin, Jose Miguel AU - Lamua Riazuelo, Jose Ramon AU - Exposito Moliner, Rosa AU - Ruiz Vilchez, Desiree AU - Veiga Cabello, Raul AU - Carlos Fernandez, Jesus AU - Noguera Pons, Jose Raul AU - Garrido Punal, Noemi Patricia AU - Giralt Celimendiz, Pedro AU - Cortes Verdu, Raul AU - Aragon Diez, Angel AU - Tomas Roura, Carlos AU - Moll Turudi, Concepcion AU - Taverner Torrent, Delia AU - Rivas Santirso, Felipe Joaquin AU - Lerma Garrido, Juan Jose AU - Garcia Portales, Rosa AU - Ordonez Palau, Sergi AU - Paredes Gonzalez-Albo, Silvia AU - Gracia Perez, Antonio AU - Conesa Mateos, Arantxa AU - Calvo Alen, Jaime AU - Grana Gil, Jenaro AU - Navarro Alonso, Maria Pilar AU - Martinez Blasco, Maria Jesus AU - RENACER StudyGrp PY - 2016 DO - 10.3109/14397595.2015.1101200 SN - 1439-7595 UR - http://hdl.handle.net/10668/19206 T2 - Modern rheumatology AB - Objective: To assess effectiveness and safety of certolizumab PEGol (CZP) in rheumatoid arthritis (RA) patients after 12 months of treatment and to detect predictors of response.Methods: Observational longitudinal prospective study of RA patients from... LA - en PB - Springer KW - Certolizumab PEGol KW - Clinical practice KW - Efficacy KW - Rheumatoid arthritis KW - Safety KW - Spanish population KW - Survival rate KW - College-of-rheumatology KW - Danish danbio registry KW - Anti-tnf therapy KW - Clinical-practice KW - Long-term KW - Plus methotrexate KW - Japanese patients KW - Gisea registry KW - Alpha agents KW - Adalimumab TI - RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database TY - research article VL - 26 ER -